Log on / register
Feedback | Support | My details
The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.
Shafer-Weaver K, Sayers T, Strobl S, Derby E, Ulderich T, Baseler M, Malyguine A
J Transl Med 2003 Dec 29, 1:14
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Commentary    
Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology
Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Fridman WH, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, Kleen TO, Lehmann PV, Liotta L, Lotze MT, Maio M, et al.
Journal of Translational Medicine 2009, 7:45 (17 June 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Commentary    
Granzyme B; the chalk-mark of a cytotoxic lymphocyte
Waterhouse NJ, Sedelies KA, Clarke CJP
Journal of Translational Medicine 2004, 2:36 (25 October 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.


Methodology    
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
Shafer-Weaver KA, Sayers T, Kuhns DB, Strobl SL, Burkett MW, Baseler M, Malyguine A
Journal of Translational Medicine 2004, 2:31 (20 September 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.